药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Methyprylon
Briakinumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Briakinumab.
Methyprylon
Gallium nitrate
The risk or severity of adverse effects can be increased when Belinostat is combined with Gallium nitrate.
Methyprylon
Glatiramer
The risk or severity of adverse effects can be increased when Belinostat is combined with Glatiramer.
Methyprylon
Interferon alfa
The risk or severity of adverse effects can be increased when Belinostat is combined with Interferon alfa.
Methyprylon
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Belinostat.
Methyprylon
Thiotepa
The risk or severity of adverse effects can be increased when Thiotepa is combined with Belinostat.
Methyprylon
Brequinar
The risk or severity of adverse effects can be increased when Brequinar is combined with Belinostat.
Methyprylon
2-Methoxyethanol
The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Belinostat.
Methyprylon
Castanospermine
The risk or severity of adverse effects can be increased when Castanospermine is combined with Belinostat.
Methyprylon
Stepronin
The risk or severity of adverse effects can be increased when Stepronin is combined with Belinostat.
Methyprylon
Ciclesonide
The risk or severity of adverse effects can be increased when Ciclesonide is combined with Belinostat.
Methyprylon
Nelarabine
The risk or severity of adverse effects can be increased when Nelarabine is combined with Belinostat.
Methyprylon
Eculizumab
The risk or severity of adverse effects can be increased when Eculizumab is combined with Belinostat.
Methyprylon
Lomustine
The risk or severity of adverse effects can be increased when Lomustine is combined with Belinostat.
Methyprylon
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Belinostat.
Methyprylon
Trilostane
The risk or severity of adverse effects can be increased when Trilostane is combined with Belinostat.
Methyprylon
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Belinostat.
Levocabastine
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Tipifarnib.
Levocabastine
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Tipifarnib.
Sibutramine
Satralizumab
The serum concentration of Lofexidine can be decreased when it is combined with Satralizumab.